Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods
The objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/full |
_version_ | 1818872433703124992 |
---|---|
author | Liying Sun Liying Sun Chi Zhang Chi Zhang Shuhua An Xiangpeng Chen Yamei Li Yamei Li Leshan Xiu Leshan Xiu Baoping Xu Zhengde Xie Junping Peng Junping Peng |
author_facet | Liying Sun Liying Sun Chi Zhang Chi Zhang Shuhua An Xiangpeng Chen Yamei Li Yamei Li Leshan Xiu Leshan Xiu Baoping Xu Zhengde Xie Junping Peng Junping Peng |
author_sort | Liying Sun |
collection | DOAJ |
description | The objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology and evaluate antibiotic therapy in the enrolled children. Sputum collected from 302 children hospitalized with CAP were analyzed using the combined-MS methods, which can detect 19 viruses and 12 bacteria related to CAP. Based on the results, appropriate antibiotics were determined using national guidelines and compared with the initial empirical therapies. Respiratory pathogens were identified in 84.4% of the patients (255/302). Co-infection was the predominant infection pattern (51.7%, 156/302) and was primarily a bacterial-viral mixed infection (36.8%, 111/302). Compared with that using culture-based methods, the identification rate for bacteria using the combined-MS methods (61.8%, 126/204) increased by 28.5% (p <0.001). Based on the results of the combined-MS methods, the initial antibiotic treatment of 235 patients was not optimal, which mostly required switching to β-lactam/β-lactamase inhibitor combinations or reducing unnecessary macrolide treatments. Moreover, using the combined-MS methods to guide antibiotic therapy showed potential to decrease the length of stay in children with severe CAP. For children with CAP, quantitative molecular testing on sputum can serve as an important complement to traditional culture methods. Early aetiology elucidated using molecular testing can help guide the antibiotic therapy. |
first_indexed | 2024-12-19T12:38:44Z |
format | Article |
id | doaj.art-ea2e57a7a42b4ba5998fc443c3768ee0 |
institution | Directory Open Access Journal |
issn | 2235-2988 |
language | English |
last_indexed | 2024-12-19T12:38:44Z |
publishDate | 2021-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular and Infection Microbiology |
spelling | doaj.art-ea2e57a7a42b4ba5998fc443c3768ee02022-12-21T20:21:04ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-07-011110.3389/fcimb.2021.695134695134Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry MethodsLiying Sun0Liying Sun1Chi Zhang2Chi Zhang3Shuhua An4Xiangpeng Chen5Yamei Li6Yamei Li7Leshan Xiu8Leshan Xiu9Baoping Xu10Zhengde Xie11Junping Peng12Junping Peng13NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Respiratory Medicine, Hebei Children’s Hospital, Hebei Medical University, Shijiazhuang, ChinaBeijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Respiratory Department, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaBeijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, ChinaKey Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaThe objective of this study was to evaluate the value of molecular methods in the management of community-acquired pneumonia (CAP) in children. Previously developed mass spectrometry (MS)-based methods combined with quantitative real-time PCR (combined-MS methods) were used to describe the aetiology and evaluate antibiotic therapy in the enrolled children. Sputum collected from 302 children hospitalized with CAP were analyzed using the combined-MS methods, which can detect 19 viruses and 12 bacteria related to CAP. Based on the results, appropriate antibiotics were determined using national guidelines and compared with the initial empirical therapies. Respiratory pathogens were identified in 84.4% of the patients (255/302). Co-infection was the predominant infection pattern (51.7%, 156/302) and was primarily a bacterial-viral mixed infection (36.8%, 111/302). Compared with that using culture-based methods, the identification rate for bacteria using the combined-MS methods (61.8%, 126/204) increased by 28.5% (p <0.001). Based on the results of the combined-MS methods, the initial antibiotic treatment of 235 patients was not optimal, which mostly required switching to β-lactam/β-lactamase inhibitor combinations or reducing unnecessary macrolide treatments. Moreover, using the combined-MS methods to guide antibiotic therapy showed potential to decrease the length of stay in children with severe CAP. For children with CAP, quantitative molecular testing on sputum can serve as an important complement to traditional culture methods. Early aetiology elucidated using molecular testing can help guide the antibiotic therapy.https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/fullcommunity-acquired pneumoniarespiratory pathogensmolecular testingmass spectrometryantibiotic therapy |
spellingShingle | Liying Sun Liying Sun Chi Zhang Chi Zhang Shuhua An Xiangpeng Chen Yamei Li Yamei Li Leshan Xiu Leshan Xiu Baoping Xu Zhengde Xie Junping Peng Junping Peng Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods Frontiers in Cellular and Infection Microbiology community-acquired pneumonia respiratory pathogens molecular testing mass spectrometry antibiotic therapy |
title | Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods |
title_full | Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods |
title_fullStr | Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods |
title_full_unstemmed | Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods |
title_short | Comprehensive Description of Pathogens and Antibiotic Treatment Guidance in Children With Community-Acquired Pneumonia Using Combined Mass Spectrometry Methods |
title_sort | comprehensive description of pathogens and antibiotic treatment guidance in children with community acquired pneumonia using combined mass spectrometry methods |
topic | community-acquired pneumonia respiratory pathogens molecular testing mass spectrometry antibiotic therapy |
url | https://www.frontiersin.org/articles/10.3389/fcimb.2021.695134/full |
work_keys_str_mv | AT liyingsun comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT liyingsun comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT chizhang comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT chizhang comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT shuhuaan comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT xiangpengchen comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT yameili comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT yameili comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT leshanxiu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT leshanxiu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT baopingxu comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT zhengdexie comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT junpingpeng comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods AT junpingpeng comprehensivedescriptionofpathogensandantibiotictreatmentguidanceinchildrenwithcommunityacquiredpneumoniausingcombinedmassspectrometrymethods |